1. Home
  2. NABL vs MRVI Comparison

NABL vs MRVI Comparison

Compare NABL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$4.37

Market Cap

825.1M

Sector

Technology

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$6.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
MRVI
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
825.1M
1.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NABL
MRVI
Price
$4.37
$6.69
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$8.31
$4.13
AVG Volume (30 Days)
1.9M
3.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
$511,430,000.00
$185,743,000.00
Revenue This Year
$11.04
$12.54
Revenue Next Year
$8.53
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
9.71
N/A
52 Week Low
$2.92
$1.99
52 Week High
$9.04
$7.44

Technical Indicators

Market Signals
Indicator
NABL
MRVI
Relative Strength Index (RSI) 55.66 60.17
Support Level $4.15 $5.67
Resistance Level $5.22 N/A
Average True Range (ATR) 0.32 0.36
MACD -0.04 -0.04
Stochastic Oscillator 55.57 57.91

Price Performance

Historical Comparison
NABL
MRVI

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: